Cargando…

Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder

Atomoxetine (ATO) is a second line medication for attention-deficit hyperactivity disorder (ADHD). We proposed that part of the therapeutic profile of ATO may be through circadian rhythm modulation. Thus, the aim of this study was to investigate the circadian gene expression in primary human-derived...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faltraco, Frank, Palm, Denise, Uzoni, Adriana, Simon, Frederick, Tucha, Oliver, Thome, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2021
Materias:	Psychiatry and Preclinical Psychiatric Studies - Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295110/ https://www.ncbi.nlm.nih.gov/pubmed/34273025 http://dx.doi.org/10.1007/s00702-021-02373-5

Ejemplares similares

Norepinephrine influences the circadian clock in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder
por: Palm, Denise, et al.
Publicado: (2021)

Dopamine adjusts the circadian gene expression of Per2 and Per3 in human dermal fibroblasts from ADHD patients
por: Faltraco, Frank, et al.
Publicado: (2021)

Remdesivir shifts circadian rhythmicity to eveningness; similar to the most prevalent chronotype in ADHD
por: Faltraco, Frank, et al.
Publicado: (2021)

Driving and attention deficit hyperactivity disorder
por: Fuermaier, Anselm B. M., et al.
Publicado: (2015)

Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study
por: Ruppert, Katrin, et al.
Publicado: (2022)

Feigning ADHD and stimulant misuse among Dutch university students
por: Fuermaier, Anselm B. M., et al.
Publicado: (2021)

Sustained attention in adult ADHD: time-on-task effects of various measures of attention
por: Tucha, Lara, et al.
Publicado: (2015)

Tryptophan modulation in individuals with attention deficit hyperactivity disorder: a systematic review
por: Dinu, Larisa Maria, et al.
Publicado: (2022)

Atypical resting-state gamma band trajectory in adult attention deficit/hyperactivity disorder
por: Tombor, László, et al.
Publicado: (2021)

Long-term changes in serum levels of lipoproteins in children and adolescents with attention-deficit/hyperactivity disorder (ADHD)
por: Huber, Franziska, et al.
Publicado: (2023)

Electrophysiological underpinnings of dysfunctional inhibitory control in adults with attention-deficit/hyperactivity disorder: evidence for reduced NoGo anteriorization
por: Papp, Szilvia, et al.
Publicado: (2023)

The impact of preschool child and maternal attention-deficit/hyperactivity disorder (ADHD) symptoms on mothers’ perceived chronic stress and hair cortisol
por: Szép, Anna, et al.
Publicado: (2021)

Adult attention-deficit/hyperactivity disorder symptoms, cognitive dysfunction and quality of life in high-dose use of benzodiazepine and Z-drug
por: Federico, Angela, et al.
Publicado: (2020)

A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study
por: Hegvik, Tor-Arne, et al.
Publicado: (2016)

Association study and a systematic meta-analysis of the VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder
por: Grünblatt, Edna, et al.
Publicado: (2019)

Growth rates of human induced pluripotent stem cells and neural stem cells from attention-deficit hyperactivity disorder patients: a preliminary study
por: Yde Ohki, Cristine Marie, et al.
Publicado: (2023)

Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder
por: Kasahara, Satoshi, et al.
Publicado: (2023)

Blink rate and blink timing in children with ADHD and the influence of stimulant medication
por: Groen, Y., et al.
Publicado: (2015)

Sweat it out? The effects of physical exercise on cognition and behavior in children and adults with ADHD: a systematic literature review
por: Den Heijer, Anne E., et al.
Publicado: (2016)

Effect of Atomoxetine on Hyperactivity in an Animal Model of Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Moon, Su Jin, et al.
Publicado: (2014)

Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder
por: Price, Maxwell Z., et al.
Publicado: (2023)

Basic processes as foundations of cognitive impairment in adult ADHD
por: Butzbach, Marah, et al.
Publicado: (2019)

Non-credible symptom report in the clinical evaluation of adult ADHD: development and initial validation of a new validity index embedded in the Conners’ adult ADHD rating scales
por: Becke, Miriam, et al.
Publicado: (2021)

ADHD at the workplace: ADHD symptoms, diagnostic status, and work-related functioning
por: Fuermaier, Anselm B. M., et al.
Publicado: (2021)

Metacognition in adult ADHD: subjective and objective perspectives on self-awareness of cognitive functioning
por: Butzbach, Marah, et al.
Publicado: (2021)

Financial judgment determination in adults with ADHD
por: Koerts, Janneke, et al.
Publicado: (2021)

Public perceptions of adult ADHD: Indications of stigma?
por: Godfrey, Emmet, et al.
Publicado: (2020)

Neuropsychological functioning of individuals at clinical evaluation of adult ADHD
por: Guo, Nana, et al.
Publicado: (2020)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
por: Hammerness, Paul, et al.
Publicado: (2009)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
por: Sumner, Calvin R, et al.
Publicado: (2009)

Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder
por: Kohn, Michael R., et al.
Publicado: (2012)

Real‐World Dosing Patterns of Atomoxetine in Adults with Attention‐Deficit/Hyperactivity Disorder
por: Kabul, Samaneh, et al.
Publicado: (2015)

Atomoxetine-Associated Eyebrow Alopecia in a Girl With Attention-Deficit/Hyperactivity Disorder
por: Zhang, Ying, et al.
Publicado: (2021)

Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder
por: Nagai, Tsutomu, et al.
Publicado: (2022)

The history of attention deficit hyperactivity disorder
por: Lange, Klaus W., et al.
Publicado: (2010)

Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

Altered urinary tetrahydroisoquinoline derivatives in patients with Tourette syndrome: reflection of dopaminergic hyperactivity?
por: Capetian, Philipp, et al.
Publicado: (2020)

Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects
por: Fujioka, Toru, et al.
Publicado: (2016)

Why the Diagnosis of Attention Deficit Hyperactivity Disorder Matters
por: Hamed, Alaa M., et al.
Publicado: (2015)

Attention Deficit Hyperactivity Disorder in the Light of the Epigenetic Paradigm
por: Schuch, Viviane, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v2lrimdgfc8cpttpiv8jq5evur